Akebia Therapeutics up 70% in the after hours is why you should consider buying biotechs and Tetraphase Pharmaceuticals down 79% is why many don't. Small-cap biotechs offer the biggest mispricing (opportunities) in the market; a promised land full of landmines. A basket of biotechs and or the ETF's (XBI, BBH) make more sense to me than a flyer with one.
Tuesday, September 8, 2015
Why You Should Consider Investing In Biotechs and Why You Don't
"Frank began his career on Wall Street nearly two decades ago. He worked alongside some of the most respected traders on the street. He quickly realized his true talents were in his ability to interpret market technicals as well as behavior. He was a full-service broker until 2011 when he decided that his no-nonsense approach and expertise was better suited as an independent rather than under the reins of the brokerage business. Since his transition, Frank founded Zor Capital LLC and had successfully managed the portfolios of high net worth individuals. Outside of the cliche cookie cutter approach. His achievements and advice have been featured by CNBC, FOX Business, Yahoo Finance, Benzinga, Wall Street Journal, and CNN Money. Frank is widely regarded as an influential trader in the industry."